16 July 2024 : Original article
Ginkgetin Pretreatment Reduces Inflammatory Response in DCD Donor Liver via JAK2/STAT3 Signaling Pathway
Jia LiuBCDE, Jiansheng XiaoAG, Qin DengBC, ZhiHui FuCD, Qi XiaoAFGDOI: 10.12659/AOT.944153
Ann Transplant 2024; 29:e944153
Figure 4 Ginkgetin alleviated DCD donor liver damage through the JAK2/STAT3 signaling pathway. (A) Protein levels of p-JAK2, JAK2, p-STAT3, and STAT3 in the livers of each group were evaluated by western blot. (B) Statistical analysis of p-JAK2/JAK2 and p-STAT3/STAT3 protein expression. Data are expressed as mean±SD, * P<0.05 and ** P<0.01. n=3 per group. All statistical analysis were performed using GraphPad Prism 8.0.1 software (San Diego, CA, USA). The grayscale values of the western blot bands were analyzed using Image J software (National Institutes of Health, Maryland, USA).